First Allied Securities hosted its annual national adviser conference this summer where 1,100 attendees participated not only in education, training,…
PatrĂcia Silva, PhD
PatrĂcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĂcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by PatrĂcia Silva, PhD
Sophia Genetics and Devyser announced a partnership to simplify the adoption of next-generation DNA sequencing (NGS) for routine diagnostic laboratories. According…
Kary Coleman, director of development and alumni relations at Penn State University’s New Kensington campus, was honored as one of…
Spyryx Biosciences recently announced that Dr. Alistair Wheeler is joining the company as its new chief medical officer. Spyryx, a clinical-stage biopharma…
Pulmatrix’s PUR1900 for Pulmonary Fungal Infections in CF Patients Granted Orphan Drug Designation
Pulmatrix‘s inhaled PUR1900 for treating pulmonary fungal infections in patients with cystic fibrosis(CF)Â has received orphan drug status…
A team of scientists from Ulster University, in Northern Ireland, United Kingdom, have joined a nearly $980,000  global research study…
The San Diego Chapter of the Cystic Fibrosis Foundation will host its inaugural Surf for CF day on the beach at…
Patients and loved ones affected by the burden of cystic fibrosis (CF) may want to take action and do something…
Savara Fully Acquires Serendex, Readies Phase 3 Trial of Inhaled Antibiotic for CF Lung Infections
Savara Pharmaceuticals announced that it has finished with the steps necessary to fully acquire Serendex Pharmaceuticals, strengthening its position as…
Alaxia SAS announced that it has received $1.7 million from the Cystic Fibrosis Foundation Therapeutics (CFFT), the non-profit drug discovery and…